Low prostate-specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomy.
about
High risk of under-grading and -staging in prostate cancer patients eligible for active surveillanceSerum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density.Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance.PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance.The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.Poor association between the progression criteria in active surveillance and subsequent histopathological findings following radical prostatectomy.
P2860
Low prostate-specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Low prostate-specific antigen ...... ncer at radical prostatectomy.
@en
Low prostate-specific antigen ...... ncer at radical prostatectomy.
@nl
type
label
Low prostate-specific antigen ...... ncer at radical prostatectomy.
@en
Low prostate-specific antigen ...... ncer at radical prostatectomy.
@nl
prefLabel
Low prostate-specific antigen ...... ncer at radical prostatectomy.
@en
Low prostate-specific antigen ...... ncer at radical prostatectomy.
@nl
P2093
P2860
P1433
P1476
Low prostate-specific antigen ...... ncer at radical prostatectomy.
@en
P2093
Adam D Toll
H Ballentine Carter
Jeong S Han
Jonathan I Epstein
Patricia Landis
Stephen Lee
P2860
P304
P356
10.1016/J.UROLOGY.2012.05.045
P407
P577
2012-08-22T00:00:00Z